Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NA 11. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112480015B details a Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN112480015B details a Pd-catalyzed one-pot method for 2-CF3 quinazolinones, offering cost reduction in pharmaceutical intermediate manufacturing via mild conditions.
Patent CN112480015B discloses a novel Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones. High efficiency, scalable process for API intermediates.
Patent CN118619879A reveals a novel Rhodium-catalyzed route for high-purity trifluoromethyl enaminones, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112480015B reveals a one-pot method for 2-trifluoromethyl quinazolinones, offering high yields and broad substrate scope for pharmaceutical intermediates.
Novel Rh-catalyzed C-H activation for trifluoromethyl enaminones. High purity pharmaceutical intermediates with scalable cost reduction.
Patent CN118619879A reveals Rh-catalyzed route for high-purity intermediates. This method offers substantial cost reduction and supply chain reliability for global pharmaceutical manufacturers seeking scalable solutions.
Novel Pd-catalyzed one-pot method for 2-CF3 quinazolinones. High yield, scalable process for API intermediates using cheap nitro compounds.
Patent CN112480015B reveals a one-pot method for 2-trifluoromethyl quinazolinones, offering high efficiency and substrate compatibility for pharmaceutical intermediates.
Patent CN113511966B details a Rh-catalyzed route for trifluoromethyl dihydrophenanthrenes. Offers high yield, mild conditions, and scalable potential for pharmaceutical intermediate manufacturing.
Novel cobalt-catalyzed C-H carbonylation for indolo[1,2-a]quinazolin-6(5H)-ones. High efficiency, scalable route for pharmaceutical intermediates.
Novel rhodium-catalyzed method for trifluoromethyl enaminones offers high purity and scalable production for pharmaceutical intermediates supply chain efficiency and cost reduction.
Patent CN118908853A reveals a safe copper-catalyzed route for high-purity acrylonitrile intermediates, offering significant supply chain and cost advantages.
Novel rhodium-catalyzed method enhances trifluoromethyl enaminone production. Delivers high purity pharmaceutical intermediates with reduced costs and scalable supply chain reliability for global buyers.
Patent CN118619879A reveals a novel Rhodium-catalyzed C-H activation route for trifluoromethyl enaminones, offering high purity and scalable pharmaceutical intermediate manufacturing.
Patent CN112480015B reveals a novel Pd-catalyzed one-pot method for quinazolinones, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN118619879A reveals Rh-catalyzed C-H activation for trifluoromethyl enaminones. Delivers high purity, cost efficiency, and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN105111208B enables efficient asymmetric hydrogenation. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112125856A details a safe palladium-catalyzed carbonylation using solid CO surrogates for high-purity quinazolinone intermediates, offering significant cost reduction.
Patent CN118619879A reveals a novel Rh-catalyzed method for trifluoromethyl enaminones. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.